ASX - By Stock
|
CKA |
Re:
Ann: Cokal Receives Payment from Loading 7,500 tonnes of Coal
|
|
Lymphnode63
|
62 |
15K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
62
|
15K
|
0
|
|
ASX - By Stock
|
CKA |
Re:
Ann: Cokal Receives Payment from Loading 7,500 tonnes of Coal
|
|
Lymphnode63
|
62 |
15K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
62
|
15K
|
0
|
|
ASX - By Stock
|
CKA |
Re:
Ann: Cokal Receives Payment from Loading 7,500 tonnes of Coal
|
|
Lymphnode63
|
62 |
15K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
62
|
15K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Lymphnode63
|
2.1K |
695K |
25 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
2.1K
|
695K
|
25
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
43 |
28/03/24 |
28/03/24 |
General
|
10K
|
3.7M
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Lymphnode63
|
2.9K |
994K |
21 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
2.9K
|
994K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Lymphnode63
|
2.9K |
994K |
2 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
2.9K
|
994K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Lymphnode63
|
231 |
65K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
231
|
65K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
Lymphnode63
|
156 |
50K |
13 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
156
|
50K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Lymphnode63
|
592 |
185K |
6 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
592
|
185K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Lymphnode63
|
592 |
185K |
13 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
592
|
185K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
Lymphnode63
|
268 |
81K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
268
|
81K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race global agreement with City of Hope to access FTO IP
|
|
Lymphnode63
|
268 |
81K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
268
|
81K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
13 |
30/05/23 |
30/05/23 |
General
|
10K
|
3.7M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
Lymphnode63
|
227 |
83K |
3 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
227
|
83K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Leadership Changes
|
|
Lymphnode63
|
559 |
179K |
4 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
559
|
179K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Lymphnode63
|
196 |
69K |
0 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
196
|
69K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Lymphnode63
|
2.9K |
994K |
6 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
2.9K
|
994K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
Lymphnode63
|
112 |
40K |
34 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
112
|
40K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma
|
|
Lymphnode63
|
91 |
33K |
2 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
91
|
33K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
Lymphnode63
|
26 |
7.1K |
10 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
26
|
7.1K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
Lymphnode63
|
26 |
7.1K |
9 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
26
|
7.1K
|
9
|
|
ASX - By Stock
|
SHP |
Re:
7.5c SP -> $1.11 SP Target (Largest Potash Deposit in West-Europe) $30M MC
|
|
Lymphnode63
|
2.1K |
613K |
0 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
2.1K
|
613K
|
0
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
3 |
19/04/22 |
19/04/22 |
General
|
10K
|
3.7M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
25 |
14/04/22 |
14/04/22 |
General
|
10K
|
3.7M
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: CEO & CSO Employment Update
|
|
Lymphnode63
|
35 |
12K |
4 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
35
|
12K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
4 |
10/04/22 |
10/04/22 |
General
|
10K
|
3.7M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Lymphnode63
|
76 |
26K |
1 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
76
|
26K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
Lymphnode63
|
76 |
26K |
8 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
76
|
26K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
IPO - Telix Pharmaceuticals Limited
|
|
Lymphnode63
|
65 |
38K |
2 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
65
|
38K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Lymphnode63
|
10K |
3.7M |
2 |
20/01/22 |
20/01/22 |
General
|
10K
|
3.7M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
Lymphnode63
|
179 |
61K |
5 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
179
|
61K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr John Cullity
|
|
Lymphnode63
|
137 |
41K |
3 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
137
|
41K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr John Cullity
|
|
Lymphnode63
|
137 |
41K |
13 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
137
|
41K
|
13
|
|
Charts
|
IMU |
Re:
Anyone else frustrated with the SP with all the positive news we have received lately?
|
|
Lymphnode63
|
263 |
130K |
4 |
10/01/22 |
10/01/22 |
Charts
|
263
|
130K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Lymphnode63
|
880 |
213K |
4 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
880
|
213K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Lymphnode63
|
880 |
213K |
3 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
880
|
213K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
PR: Weebit Nano receives first silicon demonstration wafers integrating its embedded ReRAM module
|
|
Lymphnode63
|
79 |
45K |
30 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
79
|
45K
|
30
|
|
ASX - By Stock
|
WBT |
Re:
PR: Weebit Nano receives first silicon demonstration wafers integrating its embedded ReRAM module
|
|
Lymphnode63
|
79 |
45K |
6 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
79
|
45K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Lymphnode63
|
850 |
250K |
0 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
250K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Lymphnode63
|
386 |
132K |
6 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
386
|
132K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Lymphnode63
|
386 |
132K |
2 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
386
|
132K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Lymphnode63
|
21K |
7.1M |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
21K
|
7.1M
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Lymphnode63
|
21K |
7.1M |
9 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
21K
|
7.1M
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit raises $9.9M from oversubscribed Entitlement Offer
|
|
Lymphnode63
|
31 |
14K |
0 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
31
|
14K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Lymphnode63
|
2.1K |
695K |
6 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
2.1K
|
695K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Lymphnode63
|
314 |
89K |
8 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
314
|
89K
|
8
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit raises $9.9M from oversubscribed Entitlement Offer
|
|
Lymphnode63
|
31 |
14K |
0 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
31
|
14K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit raises $9.9M from oversubscribed Entitlement Offer
|
|
Lymphnode63
|
31 |
14K |
0 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
31
|
14K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
Lymphnode63
|
557 |
158K |
5 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
557
|
158K
|
5
|
|